Ā | Disease-free survival | Overall survival | ||
---|---|---|---|---|
Ā | Hazard ratio | P | Hazard ratio | P |
Age, years | >1 | 0.603 | <1 | 0.329 |
Tumor size, cm | <1 | 0.717 | >1 | 0.999 |
Grade, I vs II | NA | 0.998 | NA | NA |
Lymphovascular invasion (present vs absent) | NA | 0.998 | NA | 0.999 |
ER (positive vs negative) | <1 | 0.139 | <1 | 0.997 |
PR (positive vs negative) | <1 | 0.580 | <1 | 0.343 |
HER2 (positive vs negative) | >1 | 0.122 | <1 | 0.998 |
Lymph node status (positive vs negative) | NA | 0.997 | NA | 0.998 |
Primary treatment (mastectomy vs lumpectomy with RT) | <1 | 0.996 | <1 | 0.997 |
Primary treatment (mastectomy vs lumpectomy without RT) | <1 | 0.997 | <1 | 0.998 |
Systemic therapy (endocrine therapy alone vs with chemotherapy) | >1 | 0.746 | NA | NA |